Kymera Therapeutics, Inc. Gains 45.51%
Mon, Jun 02, 2025 at 07:39 PM
Kymera Therapeutics, Inc. (KYMR:NASDAQ) soared at $43.13, representing a gain of 45.5%. On Mon, Jun 02, 2025, KYMR:NASDAQ hit a New 2-Week High of $43.13. The stock appeared on our News Catalysts scanner on Mon, Jun 02, 2025 at 09:33 AM in the 'BIOTECH' category. From Mon, May 19, 2025, the stock recorded 55.56% Up Days and 60.00% Green Days
About Kymera Therapeutics, Inc. (KYMR:NASDAQ)
Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases.
Top 10 Gainers:
- Lyra Therapeutics, Inc. (LYRA:NASDAQ), 310.75%
- ModivCare Inc. (MODV:NASDAQ), 96.43%
- Brand Engagement Network, Inc. (BNAI:NASDAQ), 75.63%
- Vera Therapeutics, Inc. (VERA:NASDAQ), 67.49%
- AgEagle Aerial Systems, Inc. (UAVS:NYSEMKT), 63.27%
- Hong Kong Pharma Digital Technology Holdings Limited (HKPD:NASDAQ), 58.12%
- Clene Inc. (CLNN:NASDAQ), 53.61%
- Kymera Therapeutics, Inc. (KYMR:NASDAQ), 45.51%
- Reitar Logtech Holdings Limited (RITR:NASDAQ), 41.37%
- Hyperfine, Inc. (HYPR:NASDAQ), 41.08%